Dr. Galakatos - Sporting Goods

PE Hub: Blackstone Life Sciences’ Nicholas Galakatos hails ‘new era in medicine’ Artificial intelligence, machine learning and a deeper understanding of complex chronic diseases means the world is at the beginning of a “new era in medicine,” Dr Nicholas Galakatos, global head of ... Nicholas Galakatos's most active month to dispose stocks was the month of October. 2014 saw Nicholas Galakatos paying a total of $238,227.02 for 37,197 shares, this is the most they've acquired in one ...